Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.
Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.
About two years ago, Wheeler noticed that there was an alarming number of people being diagnosed and starting treatment with late-stage cancer. In fact, Wheeler noted that about 69 percent of patients with lung cancer initially coming into the Levine Cancer Institute were diagnosed at stage 3 or higher.
After seeing success with a mobile mammogram program to reach vulnerable populations, Wheeler implemented a mobile lung cancer screening unit, too, that includes a CT scan. She discussed the unit during the ACCC 34th National Oncology Conference.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More